# Single-Blind Study of STAT-205 in Mild COVID-19

> **NCT04708327** · PHASE1 · UNKNOWN · sponsor: **Cytocom, Inc.** · enrollment: 24 (estimated)

## Conditions studied

- COVID-19

## Interventions

- **DRUG:** STAT-205

## Key facts

- **NCT ID:** NCT04708327
- **Lead sponsor:** Cytocom, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-12-05
- **Primary completion:** 2022-06-30
- **Final completion:** 2022-09-30
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2021-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04708327

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04708327, "Single-Blind Study of STAT-205 in Mild COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04708327. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*